In-hospital MACE | Group 1 (n = 50) | Group 2 (n = 50) | χ2 | FEp | Follow-up MACE | χ2 | FEp | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | Group 1 (n = 49) | Group 2 (n = 47) | |||||||
No. | % | No. | % | |||||||||
Heart failure | ||||||||||||
No | 50 | 100.0 | 49 | 98.0 | 43 | 87.8 | 44 | 93.6 | 0.970 | 0.487 | 1.010 | 1.000 |
Yes | 0 | 0.0 | 1 | 2.0 | 6 | 12.2 | 3 | 6.4 | ||||
Renal impairment | ||||||||||||
No | 49 | 98.0 | 49 | 98.0 | 44 | 89.8 | 45 | 95.7 | 1.256 | 0.436 | 0.0 | 1.000 |
Yes | 1 | 2.0 | 1 | 2.0 | 5 | 10.2 | 2 | 4.3 | ||||
Death | ||||||||||||
No | 49 | 98.0 | 47 | 94.0 | 49 | 100 | 47 | 100 | – | – | 1.042 | 0.617 |
Yes | 1 | 2.0 | 3 | 6.0 | 0 | 0.0 | 0 | 0.0 | ||||
Myocardial infarction | ||||||||||||
No | 49 | 98.0 | 49 | 98.0 | 49 | 100.0 | 46 | 97.9 | 1.054 | 0.490 | 0.0 | 1.000 |
Yes | 1 | 2.0 | 1 | 2.0 | 0 | 0.0 | 1 | 2.1 | ||||
Targeted vessel revascularization or non-target vessel revascularization | ||||||||||||
No | 50 | 100 | 50 | 100.0 | 48 | 98.0 | 45 | 95.7 | 0.389 | 0.613 | – | – |
Yes | 0 | 0.0 | 0 | 0.0 | 1 | 2.0 | 2 | 4.3 | ||||
Stroke | ||||||||||||
No | 49 | 98.0 | 48 | 96.0 | 49 | 100 | 47 | 100 | – | – | 0.344 | 1.000 |
Yes | 1 | 2.0 | 2 | 4.0 | ||||||||
Bleeding | ||||||||||||
No | 50 | 100.0 | 50 | 100.0 | – | – |